The Effects of Growth Hormone and/or Testosterone in Healthy Elderly Men: A Randomized Controlled Trial
The DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.
Abstract
Context: Declines in GH and testosterone (Te) secretion may contribute to the detrimental aging changes of elderly men. Objective: To assess the effects of near-physiological GH with/without Te administration on lean body mass, total body fat, midthigh muscle cross-section area, muscle strength, aerobic capacity, condition-specific quality of life (Age-Related Hormone Deficiency-Dependent Quality of Life questionnaire), and generic health status (36-Item Short-Form Health Survey) of older men. Design, Settings, and Participants: A 6-month, randomized, double-blind, placebo-controlled trial was performed on 80 healthy, community-dwelling, older men (age, 65–80 yr). Interventions: Participants were randomized to receive 1) placebo GH or placebo Te, 2) recombinant human GH (rhGH) and placebo Te (GH), 3) Te and placebo rhGH (Te), or 4) rhGH and Te (GHTe). GH doses were titrated over 8 wk to produce IGF-I levels in the upper half of the age-specific reference range. A fixed dose of Te (5 mg) was given by transdermal patches. Results: Lean body mass increased with GHTe (P = 0.008) and GH (P = 0.004), compared with placebo. Total body fat decreased with GHTe only (P = 0.02). Midthigh muscle (P = 0.006) and aerobic capacity (P < 0.001) increased only after GHTe. Muscle strength changes were variable; one of six measures significantly increased with GHTe. Significant treatment group by time interactions indicated an improved Age-Related Hormone Deficiency-Dependent Quality of Life questionnaire score (P = 0.007) in the GH and GHTe groups. Bodily pain increased with GH alone, as determined by the Short-Form Health Survey (P = 0.003). There were no major adverse effects. Conclusion: Coadministration of low dose GH with Te resulted in beneficial changes being observed more often than with either GH or Te alone.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Therapy with testosterone and GH in older men aged 65–80 years with normal testosterone levels resulted in greater improvements in lean mass with both treatments than with either alone56,408.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [408]
In the citing paper
“Dual therapy with testosterone and GH in older men who have normal testosterone concentrations results in improvements in lean body mass, compared with placebo or either treatment alone.87”
From Age-related and disease-related muscle loss: The effect of diabetes, obesity, and other diseases (2014) · cites this paper as [87]
In the citing paper
“However, some groups have shown that T replacement in old men does not provide significant benefits in strength 214-217 or cognition,218 increases coronary artery plaque formation,219 and is consistently shown to have no effect on insulin sensitivity.216, 220”
From Hormonal and Metabolic Changes of Aging and the Influence of Lifestyle Modifications (2021) · cites this paper as [217]
Citations
Cites
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033 · cited 4×
“The SF-36 questionnaire can be obtained from QualityMetric, Inc. (http://www.qualitymetric.com).”
MethodInfluentialBody-Mass Index and Mortality in a Prospective Cohort of U.S. Adults
Calle, E. E., Thun, M. J., Petrelli, J. M., Rodriguez, C., & Heath, C. W. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910073411501 · Cited by 3,643
Skeletal muscle mass and distribution in 468 men and women aged 18–88 yr
Janssen, I., Heymsfield, S. B., Wang, Z., & Ross, R. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.1.81 · Cited by 3,087 · cited 7×
“480 J Clin Endocrinol Metab, February 2006, 91(2):477–484 Giannoulis et al.”
BackgroundInfluentialLongitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760 · cited 1×
“Testosterone (Te) levels also decline progressively; average levels are 30% lower by age 70 yr (9).”
BackgroundLarsson, B., Svärdsudd, K., Welin, L., Wilhelmsen, L., Björntorp, P., & Tibblin, G. (1984) · BMJ · doi:10.1136/bmj.288.6428.1401 · Cited by 1,934
Effects of Human Growth Hormone in Men over 60 Years Old
Rudman, D., Feller, A. G., Nagraj, H. S., Gergans, G. A., Lalitha, P. Y., Goldberg, A. F., Schlenker, R. A., Cohn, L., Rudman, I. W., & Mattson, D. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230101 · Cited by 1,555
Salomon, F., Cuneo, R. C., Hesp, R., & Sönksen, P. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912283212605 · Cited by 1,326 · cited 1×
“In young adults, a deficiency of either GH or Te produces changes similar to the aging phenotype, which reverse after GH and/or Te replacement (10, 11).”
BackgroundSelf-citationThe Arizona Sexual Experience Scale (ASEX): Reliability and Validity
A. McGahuey, A. J. G. (2000) · Journal of Sex & Marital Therapy · doi:10.1080/009262300278623 · Cited by 1,155 · cited 1×
“Patient-reported outcomes were assessed with the specially developed condition-specific Age-Related Hormone Deficiency-Dependent Quality of Life questionnaire (A-RHDQoL) (26), the generic health-status measure Short-Form 36 (SF-36) (27), and the generic Well-Being Questionnaire (W-BQ12) (28), and sexual dysfunction wa…”
MethodAge and gender comparisons of muscle strength in 654 women and men aged 20–93 yr
Lindle, R. S., Metter, E. J., Lynch, N. A., Fleg, J. L., Fozard, J. L., Tobin, J., Roy, T. A., & Hurley, B. F. (1997) · Journal of Applied Physiology · doi:10.1152/jappl.1997.83.5.1581 · Cited by 971 · cited 3×
“A significant group by time effect was also found for SF-36 bodily pain [F(3,59) 5.”
BackgroundTestosterone dose-response relationships in healthy young men
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1172 · Cited by 967 · cited 2×
“The anabolic effect of Te on LBM has been shown recently in a series of studies to be highly dose and Te concentration dependent (31).”
BackgroundSkeletal Muscle Strength as a Predictor of All-Cause Mortality in Healthy Men
Metter, E. J., Talbot, L. A., Schrager, M., & Conwit, R. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.10.b359 · Cited by 841 · cited 1×
“Sarcopenia, due to ageassociated decreases in skeletal muscle mass and strength (2, 3), is associated with impaired mobility, falls, fractures, and higher mortality rates (4, 5).”
BackgroundIRANMANESH, A., LIZARRALDE, G., & VELDHUIS, J. D. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1081 · Cited by 672 · cited 1×
“GH secretion falls during adulthood; more than 30% of elderly people have circulating IGF-I levels below the young-normal range (8).”
BackgroundStrength is a major factor in balance, gait, and the occurrence of falls
Fukagawa, N. K., Wolfson, L., Judge, J., Whipple, R., & King, M. (1995) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/50a.special_issue.64 · Cited by 617 · cited 1×
“Sarcopenia, due to ageassociated decreases in skeletal muscle mass and strength (2, 3), is associated with impaired mobility, falls, fractures, and higher mortality rates (4, 5).”
BackgroundEffects of Testosterone Replacement in Hypogonadal Men1
Snyder, P. J., Peachey, H., Berlin, J. A., Hannoush, P., Haddad, G., Dlewati, A., Santanna, J., Loh, L., Lenrow, D. A., Holmes, J. H., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6731 · Cited by 572 · cited 2×
“The absence of significant LBM or fat changes on Te alone differs from previous studies of elderly or hypogonadal men (16, 17, 30).”
BackgroundResultBhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Mac, R. P., Lee, M., Yarasheski, K. E., Sinha-Hikim, I., Dzekov, C., Dzekov, J., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1184 · Cited by 544 · cited 1×
“The absence of significant LBM or fat changes on Te alone differs from previous studies of elderly or hypogonadal men (16, 17, 30).”
ResultEffect of Testosterone Treatment on Body Composition and Muscle Strength in Men Over 65 Years of Age
Snyder, P. J. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.8.2647 · Cited by 531 · cited 2×
“The absence of significant LBM or fat changes on Te alone differs from previous studies of elderly or hypogonadal men (16, 17, 30).”
BackgroundResultHuman Body Composition: Advances in Models and Methods
B. Heymsfield, S., Wang, Z., Baumgartner, R. N., & Ross, R. (1997) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.17.1.527 · Cited by 527 · cited 1×
“One-slice scans in the middle abdomen through the L4/L5 disc space and in the thigh midway between the anterior superior iliac spine to the superior border of the patella were performed (24).”
MethodTestosterone Replacement Increases Fat-Free Mass and Muscle Size in Hypogonadal Men1
Bhasin, S., Storer, T. W., Berman, N., Yarasheski, K. E., Clevenger, B., Phillips, J., Lee, W. P., Bunnell, T. J., & Casaburi, R. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.2.3733 · Cited by 522 · cited 3×
“strength was noticed in hypogonadal men (11) and in healthy”
BackgroundResultFerrando, A. A., Sheffield-Moore, M., Yeckel, C. W., Gilkison, C., Jiang, J., Achacosa, A., Lieberman, S. A., Tipton, K., Wolfe, R. R., & Urban, R. J. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00362.2001 · Cited by 522 · cited 2×
“mRNA for IGF-I increases after administration of Te to healthy elderly men and decreases in healthy young men after they become hypogonadal (21).”
BackgroundResultGrowth Hormone Replacement in Healthy Older Men Improves Body Composition but Not Functional Ability
Papadakis, M. A., Grady, D., Black, D., Tierney, M. J., Gooding, G. A. W., Schambelan, M., & Grunfeld, C. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-8-199604150-00002 · Cited by 474 · cited 2×
“or marginal increases (14, 16, 22, 33, 34), and demonstrable”
BackgroundEffects of Testosterone Replacement in Hypogonadal Men
Snyder, P. J. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.8.2670 · Cited by 464
Blackman, M. R. (2002) · JAMA · doi:10.1001/jama.288.18.2282 · Cited by 455
Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strength
Cuneo, R. C., Salomon, F., Wiles, C. M., Hesp, R., & Sonksen, P. H. (1991) · Journal of Applied Physiology · doi:10.1152/jappl.1991.70.2.688 · Cited by 334
Testosterone Replacement Increases Fat-Free Mass and Muscle Size in Hypogonadal Men
Bhasin, S. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.407 · Cited by 317
Taaffe, D. R. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.5.1361 · Cited by 270 · cited 1×
“or marginal increases (14, 16, 22, 33, 34), and demonstrable”
BackgroundStorer, T. W., Magliano, L., Woodhouse, L., Lee, M. L., Dzekov, C., Dzekov, J., Casaburi, R., & Bhasin, S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021231 · Cited by 250 · cited 1×
“73 Te (ng/dl) 432 (31) 487 (39) 498 (36) 495 (41) 478 (18) 0.”
Brill, K. T., Weltman, A. L., Gentili, A., Patrie, J. T., Fryburg, D. A., Hanks, J. B., Urban, R. J., & Veldhuis, J. D. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020098 · Cited by 188 · cited 2×
“This suggests that combining GH and Te may have clinical utility, and indeed, since we embarked on this study, several investigations of this therapeutic approach have been reported (22, 23).”
BackgroundJohannsson, G. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.9.2877 · Cited by 171
Skeletal muscle mass and the reduction ofV˙ o 2 max in trained older subjects
Proctor, D. N., & Joyner, M. J. (1997) · Journal of Applied Physiology · doi:10.1152/jappl.1997.82.5.1411 · Cited by 155 · cited 2×
“Discordance of muscle mass, strength, and fitness gains has also been noted in treated adult GHD patients (33, 37).”
BackgroundCohn, L., Feller, A. G., Draper, M. W., Rudman, I. W., & Rudman, D. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02388.x · Cited by 139
Welle, S. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.9.3239 · Cited by 130 · cited 2×
“Discordance of muscle mass, strength, and fitness gains has also been noted in treated adult GHD patients (33, 37).”
BackgroundKhaw, K. (1997) · BMJ · doi:10.1136/bmj.315.7115.1090 · Cited by 103
Woodhouse, L. J., Asa, S. L., Thomas, S. G., & Ezzat, S. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.12.6196 · Cited by 102 · cited 1×
“Increased fiber size was associated with gains in submaximal aerobic capacity and improved walking ability, but not strength (38).”
BackgroundWhich adults develop side-effects of growth hormone replacement?
Holmes, S. J., & Shalet, S. M. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb01908.x · Cited by 101 · cited 2×
“73 Te (ng/dl) 432 (31) 487 (39) 498 (36) 495 (41) 478 (18) 0.”
BackgroundEffects of Age on Testicular Function and Consequences of Testosterone Treatment1
Snyder, P. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7602 · Cited by 73 · cited 1×
“Thus, aging-associated declines in GH or Te secretion may contribute to detrimental aspects of aging (12, 13).”
BackgroundGROWTH HORMONE AND SEX STEROIDS
Mauras, N. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70200-0 · Cited by 72
The 12-Item Well-Being Questionnaire: origins, current stage of development, and availability.
Bradley, C. (2000) · Diabetes Care · doi:10.2337/diacare.23.6.875 · Cited by 67 · cited 3×
“For access and license to use the A-RHDQoL and W-BQ12 questionnaires, contact the copyright holder, Dr. Clare Bradley, Professor of Health Psychology, Health Psychology Research, Royal Holloway, University of London, Egham, Surrey TW20 0EX, United Kingdom.”
MethodSelf-citationDvorak, R. V. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.3.957 · Cited by 60
Cuneo, R. C., Salomon, F., Wiles, M., Round, J. M., Jones, D., Hesp, R., & Sönksen, P. H. (1992) · Hormone Research · doi:10.1159/000182276 · Cited by 51 · cited 2×
“Different physiological roles of fiber types may be a factor; in untreated GHD adults, correlations existed between proportional total type I fiber CSA and VO2max and between proportional total type II fiber CSA and strength (39).”
BackgroundEffects of Age on Testicular Function and Consequences of Testosterone Treatment
Snyder, P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.6.2369 · Cited by 41
Growth Hormone Replacement Therapy and Insulin Sensitivity
Svensson, J., & Bengtsson, B. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030218 · Cited by 21
McMillan, C., Bradley, C., Giannoulis, M. G., Martin, F. C., & Sönksen, P. H. (2003) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-1-51 · Cited by 18 · cited 1×
“Patient-reported outcomes were assessed with the specially developed condition-specific Age-Related Hormone Deficiency-Dependent Quality of Life questionnaire (A-RHDQoL) (26), the generic health-status measure Short-Form 36 (SF-36) (27), and the generic Well-Being Questionnaire (W-BQ12) (28), and sexual dysfunction wa…”
MethodSelf-citationGrowth hormone, aging and frailty
Martin, D. F. C., & Sturgess, I. (1999) · Reviews in Clinical Gerontology · doi:10.1017/s0959259899009326 · Cited by 3
Cited by
Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies
Batsis, J. A., & Villareal, D. T. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0062-9 · Cited by 1,382
Age-related and disease-related muscle loss: The effect of diabetes, obesity, and other diseases
Kalyani, R. R., Corriere, M., & Ferrucci, L. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70034-8 · Cited by 1,102
Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects
Møller, N., & Jørgensen, J. O. L. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0027 · Cited by 1,039
Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis
Fernández-Balsells, M. M., Murad, M. H., Lane, M., Lampropulos, J. F., Albuquerque, F., Mullan, R. J., Agrwal, N., Elamin, M. B., Gallegos-Orozco, J. F., Wang, A. T., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2575 · Cited by 713
Srinivas-Shankar, U., Roberts, S. A., Connolly, M. J., O'Connell, M. D. L., Adams, J. E., Oldham, J. A., & Wu, F. C. W. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1251 · Cited by 629
“Treatment with GH and T (40) and recombinant human chorionic gonadotropin (41) in healthy elderly men showed no improvement in muscle strength measured by dynamometry.”
Method
Metadata
- Authors
- Giannoulis, M. G., Sonksen, P. H., Umpleby, M., Breen, L., Pentecost, C., Whyte, M., McMillan, C. V., Bradley, C., & Martin, F. C.
- Affiliations
- Departments of Diabetes and Endocrinology (M.G.G., L.B., C.P., M.U., M.W., P.H.S.), London SE1 7EH, United Kingdom
- Royal Holloway University of London (GB)
- St Thomas' Hospital (GB)
- Corresponding author
- Martin, Finbarr C.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2006-02-01
- Volume
- 91
- Issue
- 2
- Pages
- 477-484
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2148157817
- Cited by
- 164
- References
- 46
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 3 · 2023: 1 · 2022: 3 · 2021: 3 · 2020: 2 · 2019: 5 · 2018: 10 · 2017: 3 · 2016: 8 · 2015: 4 · 2014: 6 · 2013: 14 · 2012: 3
- FWCI
- 11.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Open Research (University of Surrey) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Royal Holloway Digital Repository (Royal Holloway University of London) (submittedVersion)
- Funders
- Novo Nordisk
- Royal Holloway, University of London
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Keywords
- growth hormone, testosterone, recombinant human growth hormone, older men, aging, lean body mass, fat mass, muscle cross-sectional area, muscle strength, cardiorespiratory fitness, quality of life, insulin-like growth factor I, transdermal testosterone, adverse effects
- MeSH terms
- Aged, Aged, 80 and over, Body Composition, Double-Blind Method, Humans, Insulin-Like Growth Factor I, Male, Physical Fitness, Quality of Life, Surveys and Questionnaires, Testosterone, Muscle, Skeletal, Hand Strength, Human Growth Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.